№ lp_1_2_60911
File format: docx
Character count: 3257
File size: 26 KB
This document outlines the steps and requirements for working with NCI CIRB, including registration, protocol submission, and document management for NCI-sponsored trials.
Year:
2020
Region / City:
United States
Subject:
NCI CIRB process for research protocol approval
Document Type:
Instructional Guide
Author:
NCI CIRB
Target Audience:
Investigators, research staff, and affiliated personnel
Period of Validity:
N/A
Approval Date:
2020
Date of Last Revision:
2020
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
Boston, MA
Subject:
Clinical Trials, Consent Forms
Document Type:
Consent Form Template
Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
DF/HCC Research Team
Target Audience:
Researchers, Study Coordinators, Institutional Review Boards
Effective Period:
Ongoing
Approval Date:
2026
Revision Date:
Not specified
Year:
2018
Region / City:
Dana-Farber/Harvard Cancer Center
Topic:
Research Consent Forms
Document Type:
Institutional Consent Language
Organization / Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
N/A
Target Audience:
Research participants and their legal representatives
Effective Period:
N/A
Approval Date:
10.04.2018
Date of Changes:
N/A
Year:
2021
Region / City:
Wisconsin
Topic:
Informed Consent Form Template
Document Type:
Template
Organization / Institution:
Medical College of Wisconsin
Author:
NCI CIRB
Target Audience:
Researchers, Institutional Review Boards
Period of Validity:
Ongoing
Approval Date:
N/A
Modification Date:
N/A
Year:
2027
Region / City:
United States
Theme:
Clinical Research, Institutional Review Boards
Document Type:
Agreement
Organization / Institution:
National Cancer Institute (NCI)
Author:
National Cancer Institute (NCI)
Target Audience:
Institutions involved in clinical trials
Period of Action:
Ongoing until the expiration of agreement
Approval Date:
N/A
Date of Changes:
N/A
Year:
2019
Region / City:
United States
Topic:
Clinical Trials, Institutional Review Boards
Document Type:
Policy
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI
Target Audience:
NCTN and NCORP Sites, Clinical Trial Sites
Effective Period:
From March 1, 2019
Approval Date:
March 1, 2019
Modification Date:
Not specified
Year:
2023
Region / City:
United States
Subject:
Clinical Trial Studies, Institutional Review Board (IRB)
Document Type:
Authorization Agreement, Confidentiality Statement
Organization / Institution:
National Cancer Institute (NCI), CIRB
Author:
National Cancer Institute
Target Audience:
Institutions participating in clinical trials
Effective Period:
Until March 31, 2026
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Region / City:
Boston, MA
Subject:
Clinical Trials, Consent Forms
Document Type:
Consent Form Template
Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
DF/HCC Research Team
Target Audience:
Researchers, Study Coordinators, Institutional Review Boards
Effective Period:
Ongoing
Approval Date:
2026
Revision Date:
Not specified
Note:
Year
Subject Matter:
Research Ethics
Document Type:
Protocol
Institution:
Massachusetts Institute of Technology
Author:
Committee on the Use of Humans as Experimental Subjects
Target Audience:
Researchers and Institutions engaging in human subjects research
Contextual Description:
A protocol document for institutions requesting MIT to serve as the reviewing IRB in human subjects research.
Year:
No data
Region / City:
No data
Theme:
Christianity, Faith, Spirituality
Document Type:
Religious Text
Author:
No data
Target Audience:
Christians, Believers
Period of Action:
No data
Approval Date:
No data
Amendment Date:
No data
A sermon or religious reflection on finding joy in Christ, derived from the biblical passage John 16:
16-33.
Year:
2018
Region / City:
Dana-Farber/Harvard Cancer Center
Topic:
Research Consent Forms
Document Type:
Institutional Consent Language
Organization / Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
N/A
Target Audience:
Research participants and their legal representatives
Effective Period:
N/A
Approval Date:
10.04.2018
Date of Changes:
N/A
Document Type:
Institutional guidance document
Subject:
Reliance arrangement procedures and study team responsibilities
Related Agreement:
SMART IRB Master Common Reciprocal Institutional Review Board Authorization Agreement
Governing Procedures:
SMART IRB Standard Operating Procedures (SOPs)
Issuing Body:
Reviewing Institutional Review Board
Applicable To:
Relying Site Study Teams
Scope:
Multi-site research relying on a single IRB
Key Roles Identified:
Lead Study Team; SMART IRB Point of Contact (POC)
Topics Covered:
Communication plan; IRB approval preparation; reporting requirements; compliance obligations; key IRB policies
Referenced Materials:
Communication Plan; FAQs for Research Teams Relying on an External IRB
Regulatory Framework:
Applicable federal regulations; state and local laws; institutional requirements
Lifecycle Coverage:
Study activation, conduct, continuing review, reporting, and site closure
Institution:
Wayne State University
Department / Office:
Institutional Review Boards (IRBs)
IRB Panels:
PH1, MI, MP2 – Medical; B3 – Social, Behavioral, Education
Document Type:
Research administration form
Document Purpose:
Collection of institutional and regulatory information for reliance arrangements in human subjects research
Related Agreement:
SMART IRB Agreement (if applicable)
Regulatory Framework:
Human subjects research oversight
Related Regulation:
HIPAA (Protected Health Information)
Accreditation Reference:
AAHRPP
Research Context:
Multi-site research studies with relying institutions
Responsible Roles Mentioned:
WSU Principal Investigator (PI), Relying Institution PI, Institutional oversight personnel
Key Topics:
Institutional oversight, conflict of interest review, protocol compliance, participant protections, reporting of noncompliance, consent form language requirements, regulatory coordination
Geographic Scope:
United States and international relying institutions (when applicable)
Applicable Research Type:
Medical, social, behavioral, and educational research involving human subjects
Year:
2023
Region / City:
United States
Subject:
Cancer Care Delivery, Oncology Research
Document Type:
Submission Worksheet
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI Protocol Information Office
Target Audience:
Researchers, Investigators, Study Coordinators
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Boston, MA
Subject:
Clinical Trials, Consent Forms
Document Type:
Consent Form Template
Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
DF/HCC Research Team
Target Audience:
Researchers, Study Coordinators, Institutional Review Boards
Effective Period:
Ongoing
Approval Date:
2026
Revision Date:
Not specified
Year:
2022
Region / City:
N/A
Topic:
VA Informed Consent Addendum, NCI CIRB, Boilerplate Language Revision
Document Type:
Guidance
Organization / Institution:
Department of Veterans Affairs (VA)
Author:
ORD, Office of Research Oversight (ORO), NCI CIRB
Target Audience:
VA Facilities, Research Community
Effective Period:
N/A
Approval Date:
April 6, 2022
Date of Updates:
May 12, 2022
Contextual description:
Guidance document on revisions to VA boilerplate language for NCI studies overseen by the NCI CIRB, detailing required actions for VA Facilities.
Year:
2010
Region / City:
United States
Subject:
Clinical Research Agreement
Document Type:
Cooperative Research and Development Agreement (CRADA)
Agency / Institution:
U.S. Department of Health and Human Services (HHS)
Author:
National Cancer Institute (NCI)
Target Audience:
Researchers, Medical Institutions
Effective Date:
Upon signing by the parties
Date of Approval:
December 8, 2010
Amendment Date:
N/A
Description:
A formal agreement between the U.S. Department of Health and Human Services and external collaborators for conducting clinical research.
Year:
2018
Region / City:
Dana-Farber/Harvard Cancer Center
Topic:
Research Consent Forms
Document Type:
Institutional Consent Language
Organization / Institution:
Dana-Farber/Harvard Cancer Center (DF/HCC)
Author:
N/A
Target Audience:
Research participants and their legal representatives
Effective Period:
N/A
Approval Date:
10.04.2018
Date of Changes:
N/A
Year:
2021
Region / City:
Wisconsin
Topic:
Informed Consent Form Template
Document Type:
Template
Organization / Institution:
Medical College of Wisconsin
Author:
NCI CIRB
Target Audience:
Researchers, Institutional Review Boards
Period of Validity:
Ongoing
Approval Date:
N/A
Modification Date:
N/A
Year:
2027
Region / City:
United States
Theme:
Clinical Research, Institutional Review Boards
Document Type:
Agreement
Organization / Institution:
National Cancer Institute (NCI)
Author:
National Cancer Institute (NCI)
Target Audience:
Institutions involved in clinical trials
Period of Action:
Ongoing until the expiration of agreement
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / City:
United States
Topic:
Genomics, Implementation Science
Document Type:
Request for Approval
Organization / Institution:
National Cancer Institute (NCI)
Author:
Gila Neta
Target Audience:
Genomics researchers, NIH-funded researchers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Privacy Act Systems of Records Title:
Not specified
System or Records Notice Published:
No